Exercise News and Research

Latest Exercise News and Research

BioSante Pharmaceuticals enters into securities purchase agreements with Great Point and Deerfield Management

BioSante Pharmaceuticals, Inc. today announced that it has received commitments from two institutional investors to purchase $18 million of securities in a registered direct offering. The investors are Great Point Partners, LLC and Deerfield Management Company. BioSante expects to receive net proceeds of approximately $17.5 million after deducting placement agent fees and other offering expenses.

4 Mar 2010

Micromet reports total revenues of $4.6M for three months ended December 31, 2009

Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced its financial results for the fourth quarter and full year ended December 31, 2009. The Company also highlighted recent pipeline progress and outlined expected 2010 milestones.

4 Mar 2010

Sesame Workshop and AmeriChoice to develop bilingual education outreach program

Sesame Workshop, the nonprofit educational organization behind Sesame Street, and AmeriChoice, the UnitedHealth Group (NYSE: UNH) company that provides health benefits for state and public programs, are partnering to develop a bilingual education outreach program aimed at helping low-income families make food choices that are affordable, nutritional and set the foundation for lifelong healthy habits.

4 Mar 2010

Cornerstone Therapeutics' fourth-quarter net revenues increase 48%

Cornerstone Therapeutics Inc. today reported financial results for the three and 12 months ended December 31, 2009.

4 Mar 2010

Beneficial Alzheimer's therapies, update on prevention efforts focused at ADI International Conference

Beneficial Alzheimer's therapies that don't use drugs, and an update on prevention efforts, are the focus of the second day's plenary sessions at the 25th International Conference of Alzheimer's Disease International, March 12, 2010 at the Grand Hotel Palace, Thessaloniki, Greece.

4 Mar 2010

DiscountSupplements.com launched as industry leader in nutritional and fitness supplements

DiscountSupplements.com has launched as the industry leader in nutritional and fitness supplements. DiscountSupplements.com offers the lowest prices on over 5,000 (in stock) products and has 6 national warehouse locations enabling most orders to arrive the next day with an unbelievable flat shipping rate of only $7.99.

4 Mar 2010

SXC Health Solutions reports 2009 financial results

SXC Health Solutions Corp., announces its financial results for the three- and twelve-month periods ended December 31, 2009. Financial references are in U.S. dollars unless otherwise indicated.

4 Mar 2010

Soccer can be effective training method to reduce bone weakening that comes with increasing age

The observed improvements in bone mineral density, strength and postural balance due to recreational soccer are of particularly interest for a large group of women but also for elderly men, says project leader Associate Professor Peter Krustrup, University of Copenhagen, and continues "It is well known that the risk of falls and fractures increases with age as a result of weaker bones, poorer balance and attenuated ability to trigger rapid muscle force, but the present results suggest that soccer - and possibly other ball games - is an effective training method to reduce bone weakening that comes with increasing age".

4 Mar 2010

Study analyzes the role of exercise treatment in mood swings

A paper that is published in the current issue of Psychotherapy and Psychosomatics analyzes the role of exercise treatment in mood swings.

4 Mar 2010

Embedded wireless sensors in senior's homes to detect onset of dementia or physical infirmities

Carnegie Mellon University researchers in the Quality of Life Technology Center (QoLTC) will embed wireless sensors in the residences of about 50 older adults who live alone to see if they can detect subtle changes in everyday activities that indicate the onset of dementia or physical infirmities.

4 Mar 2010

SEBM announces the 2010 winners of Young Investigator Award

SEBM is pleased to announce the 2010 winners of the Young Investigator Award. This is a $500 travel grant for undergraduate/ graduate students and/or individuals within 5 years of receiving doctoral degrees who are members of the Society to attend the Experimental Biology 2010 meeting in Anaheim in April 2010.

4 Mar 2010

Data from FAME Phase 3 study for Iluvien presented at Angiogenesis 2010

pSivida Corp., a leader in the development of ophthalmic sustained release drug delivery products, with two of the only three such products approved by the FDA for treatment of back of the eye diseases, today said that 24-month data from the FAME Phase 3 study for Iluvien presented at Angiogenesis 2010 included additional efficacy and safety data that reinforced the positive top-line results reported in December 2009 by pSivida and its licensee, Alimera Sciences, Inc.

4 Mar 2010

Study finds early surgical treatment may benefit people who suffer from biceps injuries

People who suffer from injuries to the distal biceps tendon may benefit from earlier surgical intervention and new surgical techniques, according to a review article published in the March 2010 issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS).

3 Mar 2010

Merck’s MF/F Phase III study data presented at AAAAI annual meeting

Data from two Phase III studies of Merck’s investigational fixed-dose combinations of mometasone furoate and formoterol fumarate (MF/F) were presented by researchers today in two poster presentations at the American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting.

3 Mar 2010

RMR can non-invasively, quickly and accurately detect presence of sCAD

Newly published data shows using a Respiratory Modulation Response (RMR) is a novel, non-invasive measure to quickly and accurately detect the presence of significant coronary artery disease (sCAD). Patients in the study with sCAD had a lower RMR compared to patients without, regardless of their risk factors or clinical history of angina, previous myocardial infarction (MI), or angioplasty.

3 Mar 2010

China Nepstar Chain Drugstore reports revenues of US$91 million for fourth-quarter 2009

China Nepstar Chain Drugstore Ltd., the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the fourth quarter and the fiscal year ended December 31, 2009.

3 Mar 2010

Exercising during weight regain can help improve metabolic health and disease risk

With the obesity rate rising for American adults and children, health concerns such as diabetes and cardiovascular disease are a frequent reality. Although obesity itself is a major risk factor for disease, most of the threat may be associated with a cluster of risk factors called the metabolic syndrome (MetS). Losing weight can improve health and reduce these risk factors, but many people have difficulty keeping the weight off.

3 Mar 2010

EMA accepts the filing of Lux Biosciences' MAA for Luveniq

Lux Biosciences, Inc. today announced that the European Medicines Agency has accepted the filing of the company’s Marketing Authorization Application (MAA) for the company’s lead product, Luveniq™ (LX211; oral voclosporin) for the treatment of noninfectious uveitis involving the intermediate or posterior segments of the eye.

3 Mar 2010

Drinking coffee may lower risk of hospitalization for heart rhythm disturbances

Coffee drinkers may be less likely to be hospitalized for heart rhythm disturbances, according to a new study by the Kaiser Permanente Division of Research in Oakland, Calif. The researchers, who note the findings may be surprising because patients frequently report palpitations after drinking coffee, are presenting the study at the American Heart Association's 50th Annual Conference on Cardiovascular Disease Epidemiology and Prevention in San Francisco on March 5, 2010.

3 Mar 2010

ImmunoCellular Therapeutics receives Notice of Allowance on ICT-69 monoclonal antibody

ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune based therapies for the treatment of various forms of cancer, announced today it received a Notice of Allowance on monoclonal antibody ICT-69 which targets multiple myeloma and ovarian cancers. The antibody has demonstrated high specificity to these cancers by targeting a novel cell surface antigen.

2 Mar 2010

Exercise News and Research

Latest Exercise News and Research

BioSante Pharmaceuticals enters into securities purchase agreements with Great Point and Deerfield Management

Micromet reports total revenues of $4.6M for three months ended December 31, 2009

Sesame Workshop and AmeriChoice to develop bilingual education outreach program

Cornerstone Therapeutics' fourth-quarter net revenues increase 48%

Beneficial Alzheimer's therapies, update on prevention efforts focused at ADI International Conference

DiscountSupplements.com launched as industry leader in nutritional and fitness supplements

SXC Health Solutions reports 2009 financial results

Soccer can be effective training method to reduce bone weakening that comes with increasing age

Study analyzes the role of exercise treatment in mood swings

Embedded wireless sensors in senior's homes to detect onset of dementia or physical infirmities

SEBM announces the 2010 winners of Young Investigator Award

Data from FAME Phase 3 study for Iluvien presented at Angiogenesis 2010

Study finds early surgical treatment may benefit people who suffer from biceps injuries

Merck’s MF/F Phase III study data presented at AAAAI annual meeting

RMR can non-invasively, quickly and accurately detect presence of sCAD

China Nepstar Chain Drugstore reports revenues of US$91 million for fourth-quarter 2009

Exercising during weight regain can help improve metabolic health and disease risk

EMA accepts the filing of Lux Biosciences' MAA for Luveniq

Drinking coffee may lower risk of hospitalization for heart rhythm disturbances

ImmunoCellular Therapeutics receives Notice of Allowance on ICT-69 monoclonal antibody

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exercise News and Research

Latest Exercise News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in